Psilocybin in the Treatment of Mood and Substance Use Disorders

Psilocybin is examined for its potential to treat mood and substance use disorders through structured, guided sessions in a clinical setting. Research shows that psilocybin creates profound mystical and transcendent experiences that can lead to lasting, positive behavioral changes. These persistent improvements in well-being often manifest as decreased cravings, increased patient optimism, and enhanced psychological flexibility, distinguishing it from conventional, daily medication. Clinical trials highlight that controlled administration under professional supervision provides safe and effective support, particularly for end-of-life distress and treatment-resistant conditions. While challenging experiences can occur, preparation and integration are key to managing these effects for therapeutic benefit.